Pre-analytical and analytical variability in absolute quantitative MRM-based plasma proteomic studies

Bioanalysis

Volumn 5, Issue 22, 2013, Pages 2837-2856

  Percy, Andrew J ^a   Parker, Carol E ^a   Borchers, Christoph H ^a  

^a UNIVERSITY OF VICTORIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARBON 13; NITROGEN 15; PLASMA PROTEIN; TRYPSIN;

ANALYTIC METHOD; AUTOMATION; BLOOD ANALYSIS; BLOOD SAMPLING; BLOOD STORAGE; CHEMICAL REACTION; DEPLETION; FREEZE THAWING; HEMOLYSIS; HUMAN; ISOTOPE LABELING; MULTIPLE REACTION MONITORING; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEOMICS; QUANTITATIVE ANALYSIS; QUANTITATIVE PLASMA PROTEOMICS; REVIEW; ROBOTICS; STANDARDIZATION; STUDY DESIGN;

ANIMALS; BLOOD PROTEINS; CHROMATOGRAPHY, LIQUID; HUMANS; MASS SPECTROMETRY; PROTEOMICS;

EID: 84887905619     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.13.245     Document Type: Review

References (142)

1. Hossain M, Robinson EW, Liu T et al. Enhanced sensitivity for selected reaction monitoring mass spectrometry-based targeted proteomics using a dual stage electrodynamic ion funnel interface. Mol. Cell. Proteomics 10(2), doi:10.1074/mcp.M000062-MCP201 (2011
2. Yates JR, Ruse CI, Nakorchevsky A. Proteomics by mass spectrometry: Approaches, advances, and applications. Annu. Rev. Biomed. Eng. 11, 49-79 (2009
3. Domon B, Aebersold R. Mass spectrometry and protein analysis. Science 312(5771), 212-217 (2006
4. Han X, Aslanian A, Yates Jr. Mass spectrometry for proteomics. Curr. Opin. Chem. Biol. 12(5), 483-490 (2008
5. Ibrahim Y, Tang K, Tolmachev AV, Shvartsburg AA, Smith R. Improving mass spectrometer sensitivity using a high-pressure electrodynamic ion funnel interface. J. Am. Soc. Mass Spectrom. 17(9), 1299-1305 (2006 (Pubitemid 44292013)
6. Du Y, Parks BA, Sohn S, Kwast KE, Kelleher NL. Top-down approaches for measuring expression ratios of intact yeast proteins using Fourier transform mass spectrometry. Anal. Chem. 78(3), 686-694 (2006 (Pubitemid 43228574)
7. Meng F, Cargile BJ, Patrie SM, Johnson JR, McLoughlin SM, Kelleher NL. Processing complex mixtures of intact proteins for direct analysis by mass spectrometry. Anal. Chem. 74(13), 2923-2929 (2002 (Pubitemid 34755203)
8. Kelleher NL, Lin HY, Valaskovic GA, Aaserud DJ, Fridriksson EK, McLafferty FW. Top down versus bottom up protein characterization by tandem high-resolution mass spectrometry. J. Am. Chem. Soc. 121(4), 806-812 (1999
9. Link AJ, Eng J, Schieltz DM et al. Direct analysis of protein complexes using mass spectrometry. Nat. Biotechnol. 17(7), 676-682 (1999 (Pubitemid 29316146)
10. Tabb DL, McDonald WH, Yates Jr 3rd. DTASelect and contrast: Tools for assembling and comparing protein identifications from shotgun proteomics. J. Proteome Res. 1(1), 21-26 (2002
11. Washburn MP, Wolters D, Yates Jr 3rd. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotech. 19(3), 242-247 (2001 (Pubitemid 32220565)
12. Ong S, Mann M. Mass spectrometry-based proteomics turns quantitative. Nat. Chem. Biol. 1(5), 252-262 (2005
13. Schulze WX, Usadel B. Quantitation in mass-spectrometry-based proteomics. Annu. Rev. Plant Biol. 61, 491-516 (2010
14. Bantscheff M, Schirle M, Sweetman G, Rick J, Kuster B. Quantitative mass spectrometry in proteomics: A critical review. Anal. Bioanal. Chem. 389(4), 1017-1031 (2007 (Pubitemid 47482251)
15. Elliott M, Smith D, Kuzyk M, Parker CE, Borchers CH. Recent trends in quantitative proteomics. J. Mass Spectrom. 44(12), 1637-1660 (2009
16. Picotti P, Aebersold R. Selected reaction monitoring-based proteomics: Workflows, potential, pitfalls and future directions. Nat. Methods 9(6), 555-566 (2012
17. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechol. 17(10), 994-999 (1999 (Pubitemid 29474856)
18. Ross PL, Huang YN, Marchese JN et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 3(12), 1154-1169 (2004
19. Dayon L, Sanchez JC. Relative protein quantification by MS/MS using the tandem mass tag technology. Methods Mol. Biol. 893, 115-127 (2012
20. Gerber SA, Rush J, Stemman O, Kirschner MW, Gygi SP. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc. Natl Acad. Sci. USA 100(12), 6940-6945 (2003 (Pubitemid 36706372)
21. Huttenhain R, Malmstrom J, Picotti P, Aebersold R. Perspectives of targeted mass spectrometry for protein biomarker verification. Curr. Opin. Chem. Biol. 13(5-6), 518-525 (2009
22. Brun V, Masselon C, Garin J, Dupuis A. Isotope dilution strategies for absolute quantitative proteomics. J. Proteomics 72, 740-749 (2009
23. Anderson L, Hunter CL. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol. Cell. Proteomics 5(4), 573-588 (2006
24. Abdi F, Quinn JF, Jankovic J et al. Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. J. Alzheimers Dis. 9(3), 293-348 (2006 (Pubitemid 44253348)
25. Elschenbroich S, Ignatchenko V, Clarke B et al. In-depth proteomics of ovarian cancer ascites: Combining shotgun proteomics and selected reaction monitoring mass spectrometry. J. Proteome Res. 10(5), 2286-2299 (2011
26. Beaglehole R, Bonita R, Horton R et al. Priority actions for the non-communicable disease crisis. Lancet 377(9775), 1438-1447 (2011
27. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 3(11), e442 (2006
28. Verma S, Yeh ET. C-reactive protein and atherothrombosis-beyond a biomarker: An actual partaker of lesion formation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 5(285), 5 (2003
29. Zakynthinos E, Pappa N. Inflammatory biomarkers in coronary artery disease. J. Cardiol. 53, 53(3), 317-333 (2009
30. Anderson NL, Anderson NG. The human plasma proteome: History, character, and diagnostic prospects. Mol. Cell. Proteomics 1(11), 845-867 (2002
31. Brun V, Dupuis A, Adrait A et al. Isotope-labeled protein standards: Toward absolute quantitative proteomics. Mol. Cell. Proteomics 6(12), 2139-2149 (2007
32. Lebert D, Dupuis A, Garin J, Bruley C, Brun V. Production and use of stable isotope-labeled proteins for absolute quantitative proteomics. Methods Mol. Biol. 753, 93-115 (2011
33. Kirkpatrick DS, Gerber SA, Gygi SP. The absolute quantification strategy: A general procedure for the quantification of proteins and post-Translational modifications. Methods 35(3), 265-273 (2005 (Pubitemid 40255592)
34. Kettenbach AN, Rush J, Gerber SA. Absolute quantification of protein and post-Translational modification abundance with stable isotope-labeled synthetic peptides. Nat. Protoc. 6(2), 175-186 (2011
35. Percy AJ, Chambers AG, Yang J, Borchers CH. Multiplexed MRM-based quantitation of candidate cancer biomarker proteins in undepleted and non-enriched human plasma. Proteomics 13(14), 2202-2215 (2013
36. Percy AJ, Chambers AG, Yang J, Domanski D, Borchers CH. Comparison of standard-flow and nano-flow liquid chromatography systems for MRM-based quantitation of putative plasma biomarker proteins. Anal. Bioanal. Chem. 404(4), 1089-1101 (2012
37. Chambers AG, Percy AJ, Yang J, Camenzind AG, Borchers CH. Multiplexed quantitation of endogenous proteins in dried blood spots by multiple reaction monitoring mass spectrometry. Mol. Cell. Proteomics 12(3), 781-791 (2013
38. Domanski D, Percy AJ, Yang J et al. MRM-based multiplexed quantitation of 67 putative cardiovascular disease biomarkers in human plasma. Proteomics 12(8), 1222-1243 (2012
39. Kuzyk MA, Smith D, Yang J et al. Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma. Mol. Cell. Proteomics 8(8), 1860-1877 (2009
40. Keshishian H, Addona T, Burgess M, Kuhn E, Carr SA. Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution. Mol. Cell. Proteomics 6, 2212-2229 (2007
41. Keshishian H, Addona T, Burgess M et al. Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution. Mol. Cell. Proteomics 8, 2339-2349 (2009
42. Rezeli M, Végvári A, Ottervald J, Olsson T, Laurell T, Marko-Varga G. MRM assay for quantitation of complement components in human blood plasma-A feasibility study on multiple sclerosis. J. Proteomics 75(1), 211-220 (2011
43. Liu T, Hossain M, Schepmoes AA et al. Analysis of serum total and free PSA using immunoaffinity depletion coupled to MRM: Correlation with clinical immunoassay tests. J. Proteomics 75(15), 4747-4757 (2012
44. Hüttenhain R, Soste M, Selevsek N et al. Reproducible quantification of cancer-Associated proteins in body fluids using targeted proteomics. Sci. Transl. Med. 4(142), 1-13 (2012
45. Razavi M, Frick LE, LaMarr WA et al. High-Throughput SISCAPA quantitation of peptides from human plasma digests by ultrafast, liquid chromatography-free mass spectrometry. J. Proteome Res. 11(12), 5642-5649 (2012
46. Whiteaker JR, Zhao L, Anderson L, Paulovich AG. An automated and multiplexed method for high throughput peptide immunoaffinity enrichment and multiple reaction monitoring mass spectrometry-based quantification of protein biomarkers. Mol. Cell. Proteomics 9(1), 184-196 (2010
47. Kuhn E, Addona T, Keshishian H et al. Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry. Clin. Chem. 55(6), 1108-1117 (2009
48. Shi T, Fillmore TL, Sun X et al. Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum. Proc. Natl Acad. Sci. USA 109(38), 15395-15400 (2012
49. Lundblad RL. Considerations for the use of blood plasma and serum for proteomic analysis. The Internet Journal of Genomics and Proteomics. 1(2) doi:10.5580 (2005
50. Lippi G, Franchini M, Montagnana M, Salvagno GL, Poli G, Guidi GC. Quality and reliability of routine coagulation testing: Can we trust that sample? Blood Coagul. Fibrinolysis 17(7), 513-519 (2006 (Pubitemid 44434960)
51. Gelfand CA, Omenn GS. Pre-Analytical variables for plasma and serum proteome analyses. In: Sample Preparation in Biological Mass Spectrometry. Ivanov AR, Lazarev AV (Eds). Springer, Heidelberg, Germany, 269-290 (2011
52. Lista S, Faltraco F, Hampel H. Biological and methodical challenges of blood-based proteomics in the field of neurological research. Prog. Neurobiol. 101-102, 18-34 (2013
53. Rai AJ, Vitzthum F. Effects of pre-Analytical variables on peptide and protein measurements in human serum and plasma: Implications for clinical proteomics. Expert Rev. Proteomics 3(4), 409-426 (2006 (Pubitemid 44231984)
54. Yi J, Craft D, Gelfand CA. Minimizing pre-Analytical variation of plasma samples by proper blood collection and handling. Methods Mol. Biol. 728, 137-149 (2011
55. Rodriguez H, Težak Z, Mesri M et al. Analytical validation of protein-based multiplex assays: A workshop report by the NCI-FDA Interagency Oncology Task Force on Molecular Diagnostics. Clin. Chem. 56(2), 237-243 (2010
56. Paulovich AG, Billheimer DD, Ham A-JL et al. A CPTAC inter-laboratory study characterizing a yeast performance standard for benchmarking LC-MS platform performance. Mol. Cell. Proteomics 9, 242-254 (2010
57. Rodriguez H, Rivers R, Kinsinger C et al. Reconstructing the pipeline by introducing multiplexed multiple reaction monitoring mass spectrometry for cancer biomarker verification: An NCI-CPTC initiative perspective. Proteomics Clin. Appl. 4(12), 904-914 (2010
58. Kinsinger CR, Apffel J, Baker M et al. Recommendations for mass spectrometry data quality metrics for open access data (corollary to the Amsterdam Principles). J. Proteome Res. 11(2), 1412-1419 (2011
59. Addona TA, Abbatiello SE, Schilling B et al. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat. Biotechnol. 27(7), 633-641 (2009
60. Proc JL, Kuzyk MA, Hardie DB et al. A quantitative study of the effects of chaotropic agents, surfactants, and solvents on the digestion efficiency of human plasma proteins by trypsin. J. Proteome Res. 9(10), 5422-5437 (2010
61. Benoy I, Salgado R, Colpaert C, Weytjens R, Vermeulen PB, Dirix LY. Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients. Clin. Breast Cancer 2(4), 311-315 (2002 (Pubitemid 34196274)
62. Caisey JD, King DJ. Clinical chemical values for some common laboratory animals. Clin. Chem. 26(13), 1877-1879 (1980 (Pubitemid 11205484)
63. Omenn GS, States DJ, Adamski M et al. Overview of the HUPO plasma proteome project: Results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-Available database. Proteomics 5(13), 3226-3245 (2005 (Pubitemid 41192032)
64. Omenn GS. The HUPO human plasma proteome project. Proteomics Clin. Appl. 1(8), 769-779 (2007
65. Omenn GS. The Human Proteome Organization Plasma Proteome Project pilot phase: Reference specimens, technology platform comparisons, and standardized data submissions and analyses. Proteomics 4, 1235-1240 (2004 (Pubitemid 38648012)
66. Ohlund LB, Hardie DB, Elliott MHet al. Standard operating procedures and protocols for the preparation and analysis of plasma samples using the iTRAQ methodology. In: Sample Preparation in Biological Mass Spectrometry. Ivanov A, Lazarev A (Eds). Springer, NY, USA, 575-624 (2011
67. O'Mullan P, Craft D, Yi J, Gelfand CA. Thrombin induces broad spectrum proteolysis in human serum samples. Clin. Chem. Lab. Med. 47(6), 685-693 (2009
68. Rai AJ, Gelfand CA, Haywood BC et al. HUPO Plasma Proteome Project specimen collection and handling: Towards the standardization of parameters for plasma proteome samples. Proteomics 5, 3262-3277 (2005 (Pubitemid 41192034)
69. Hulmes JD, Bethea D, Ho K et al. An investigation of plasma collection, stabilization, and storage procedures for proteomic analysis of clinical samples. Clin. Proteomics 1(1), 17-31 (2004 (Pubitemid 41271307)
70. Yi J, Kim C, Gelfand CA. Inhibition of intrinsic proteolytic activities moderates pre-Analytical variability and instability of human plasma. J. Proteome Res. 6(5), 1768-1781 (2007 (Pubitemid 46814501)
71. Aguilar-Mahecha A, Kuzyk MA, Domanski D, Borchers CH, Basik M. Comparison of blood collection tubes and processing protocols for plasma proteomics studies. PLoS ONE 7(6), e38290 (2012
72. Zimmerman LJ, Li M, Yarbrough WG, Slebos RJ, Liebler DC. Global stability of plasma proteomes for mass spectrometry-based analyses. Mol. Cell. Proteomics 11(6), M111.014340 (2012
73. Randall SA, McKay MJ, Pascovici D et al. Remarkable temporal stability of high-Abundance human plasma proteins assessed by targeted mass spectrometry. Proteomics Clin. Appl. 6(11-12), 626-634 (2012
74. Ostroff R, Foreman T, Keeney TR, Stratford S, Walker JJ, Zichi D. The stability of the circulating human proteome to variations in sample collection and handling procedures measured with an aptamer-based proteomics array. J. Proteomics 73, 649-666 (2010
75. Aziz N, Nishanian P, Mitsuyasu R, Detels R, Fahey JL. Variables that affect assays for plasma cytokines and soluble activation markers. Clin. Diagn. Lab. Immunol. 6(1), 89-95 (1999 (Pubitemid 29035646)
76. Martino TA, Tata N, Bjarnason GA, Straume M, Sole MJ. Diurnal protein expression in blood revealed by high throughput mass spectrometry proteomics and implications for translational medicine and body. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293, R1430-R1437 (2007 (Pubitemid 47364642)
77. Robles MS, Mann M. Proteomic approaches in circadian biology. Handb. Exp. Pharmacol. 217, 389-407 (2013
78. Ito Y, Nakachi K, Imai K et al. Stability of frozen serum levels of insulin-like growth factor-I, insulin-like growth factor-II, insulin-like growth factor binding protein-3, transforming growth factor beta, soluble Fas, and superoxide dismutase activity for the JACC study. J. Epidemiol. 15(Suppl. 1), S67-S73 (2005 (Pubitemid 41403844)
79. Insenser M, Martínez-García M, Nieto RM, San-Millán JL, Escobar-Morreale HF. Impact of the storage temperature on human plasma proteomic analysis: Implications for the use of human plasma collections in research. Proteomics Clin. Appl. 4(8-9), 739-744 (2010
80. Markiewski MM, Nilsson B, Ekdahl KN, Mollnes TE, Lambris JD Complement and coagulation: Strangers or partners in crime? Trends Immunol. 28, 184-192 (2007 (Pubitemid 46476881)
81. Murphy BM, Swarts S, Mueller BM, van der Geer P, Manning MC, Fitchmun MI. Protein instability following transport or storage on dry ice. Nat. Methods 10(4), 278-279 (2013
82. Betsou F, Beaudeux J-L, Berthelaix A et al. Procédure pour tester l'impact des variables préanalytiques sur des analyses peptidiques et protéiques et proposition de codage des procédures préanalytiques. Ann. Biol. Clin. (Paris) 67(6), 641-649 (2009
83. Tuck MK, Chan DW, Chia D et al. Standard operating procedures for serum and plasma collection: Early detection research network consensus statement standard operating procedure integration working group. J. Proteome Res. 8, 113-117 (2009
84. Polaskova V, Kapur A, Khan A, Molloy MP, Baker MS. High-Abundance protein depletion: Comparison of methods for human plasma biomarker discovery. Electrophoresis 31(3), 471-482 (2010
85. Anderson NL, Anderson NG, Haines LR, Hardie DB, Olafson RW, Pearson TW. Mass spectrometric quantitation of peptides and proteins using stable isotope standards and capture by anti-peptide antibodies (SISCAPA). J. Proteome Res. 3(2), 235-244 (2004 (Pubitemid 38500990)
86. Anderson NL, Jackson A, Smith D, Hardie D, Borchers C, Pearson TW. SISCAPA peptide enrichment on magnetic beads using an in-line bead trap device. Mol. Cell. Proteomics 8(5), 995-1005 (2009
87. Whiteaker JR, Zhao L, Abbatiello SE et al. Evaluation of large scale quantitative proteomic assay development using peptide affinity-based mass spectrometry. Mol. Cell. Proteomics 10(4), M110.005645 (2011
88. Schoenherr RM, Zhao L, Whiteaker JR et al. Automated screening of monoclonal antibodies for SISCAPA assays using a magnetic bead processor and liquid chromatography-selected reaction monitoring-mass spectrometry. J Immunol. Methods 353(1-2), 49-61 (2010
89. Jiang J, Parker CE, Fuller JR, Kawula TH, Borchers CH. An immunoaffinity tandem mass spectrometry (iMALDI) assay for detection of Francisella tularensis. Anal. Chim. Acta 605, 70-79. (2007 (Pubitemid 350088652)
90. Jiang J, Parker CE, Hoadley KA, Perou CM, Boysen G, Borchers CH. Development of an immuno tandem mass spectrometry (iMALDI) assay for EGFR diagnosis. Proteomics Clin. Appl. 1, 1651-1659 (2007
91. Reid JD, Holmes DT, Mason DR, Shah B, Borchers CH. Towards the development of an immuno MALDI (iMALDI) mass spectrometry assay for the diagnosis of hypertension. J. Am. Soc. Mass Spectrom. 21(10), 1680-1686 (2010
92. Mason DR, Reid JD, Camenzind AG, Holmes DT, Borchers CH Duplexed iMALDI for the detection of angiotensin I and angiotensin II. Methods 56(2), 213-222 (2012
93. Polaskova V, Kapur A, Khan A, Molloy MP, Baker MS. High-Abundance protein depletion: Comparison of methods for human plasma biomarker discovery. Electrophoresis 31(3), 471-482 (2010
94. Kim K, Yu J, Min H et al. Online monitoring of immunoaffinity-based depletion of high-Abundance blood proteins by UV spectrophotometry using enhanced green fluorescence protein and FITC-labeled human serum albumin. Proteome Sci. 8, 62 (2010
95. Olsen JV, Ong SE, Mann M. Trypsin cleaves exclusively C-Terminal to arginine and lysine residues. Mol. Cell. Proteomics 3(6), 608-614 (2004 (Pubitemid 38878520)
96. Picotti P, Aebersold R, Domon B. The implications of proteolytic background for shotgun proteomics. Mol. Cell. Proteomics 6(9), 1589-1598 (2007 (Pubitemid 47506169)
97. Lin S, Yao G, Qi D et al. Fast and efficient proteolysis by microwave-Assisted protein digestion using trypsin-immobilized magnetic silica microspheres. Anal. Chem. 80(10), 3655-3665 (2008 (Pubitemid 351705865)
98. Wang N, Li L. Reproducible microwave-Assisted acid hydrolysis of proteins using a household microwave oven and its combination with LC-ESI-MS/MS for mapping protein sequences and modifications. J. Am. Soc. Mass Spectrom. 21(9), 1573-1587 (2010
99. Ye X, Li L. Microwave-Assisted protein solubilization for mass spectrometry-based shotgun proteome analysis. Anal. Chem. 84(14), 6181-6191 (2012
100. López-Ferrer D, Capelo JL, Vázquez J. Ultra fast trypsin digestion of proteins by high intensity focused ultrasound. J. Proteome Res. 4, 1569-1574 (2005 (Pubitemid 41464782)
101. López-Ferrer D, Petritis K, Hixson KK et al. Application of pressurized solvents for ultrafast trypsin hydrolysis in proteomics: Proteomics on the fly. J. Proteome Res. 7(8), 3276-3281 (2008
102. López-Ferrer D, Petritis K, Lourette NM et al. On-line digestion system for protein characterization and proteome analysis. Anal. Chem. 23, 8930-8936 (2008
103. Glatter T, Ludwig C, Ahrné E, Aebersold R, Heck AJ, Schmidt A. Large-scale quantitative assessment of different in-solution protein digestion protocols reveals superior cleavage efficiency of tandem LysC/trypsin proteolysis over trypsin digestion. J. Proteome Res. 11(11), 5145-5156 (2012
104. Canas B, Pineiro C, Calvo E, Lopez-Ferrer D, Gallardo JM. Trends in sample preparation for classical and second generation proteomics. J. Chromatog. A 1153, 235-258 (2007 (Pubitemid 46755189)
105. Zhou J, Zhou TY, Cao R et al. Evaluation of the application of sodium deoxycholate to proteomic analysis of rat hippocampal plasma membrane.rat hippocampal plasma membrane. J. Proteome Res. 5, 2547-2553 (2006 (Pubitemid 44595157)
106. Lin Y, Zhou J, Bi D, Chen P, Wang X, Liang S. Sodium-deoxycholate- Assisted tryptic digestion and identification of proteolytically resistant proteins. Anal. Biochem. 377(2), 259-266 (2008
107. Burkhart JM, Schumbrutzki C, Wortelkamp S, Sickmann A, Zahedi RP. Systematic and quantitative comparison of digest efficiency and specificity reveals the impact of trypsin quality on MS-based proteomics. J. Proteomics 75(4), 1454-1462 (2012
108. Keil B. Specificity of Proteolysis. Springer-Verlag, Berlin, Germany (1992
109. Rodriguez J, Gupta N, Smith RD, Pevzner PA Does trypsin cut before proline? J. Proteome Res. 7(1), 300-305 (2008 (Pubitemid 351171143)
110. Domanski D, Cohen Freue G, Sojo L et al. The use of multiplexed MRM for the discovery of biomarkers to differentiate iron-deficiency anemia from anemia of inflammation. J. Proteomics 75(12), 3514-3528 (2012
111. Domanski D, Smith DS, Miller CA et al. High-flow multiplexed MRM-based analysis of proteins in human plasma without depletion or enrichment. Clin. Lab. Med. 31(3), 371-384 (2011
112. Gillette MA, Carr SA. Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry. Nat. Methods 10, 28-34 (2013
113. Kuhn E, Whiteaker JR, Mani DR et al. Interlaboratory evaluation of automated, multiplexed peptide immunoaffinity enrichment coupled to multiple reaction monitoring mass spectrometry for quantifying proteins in plasma. Mol. Cell. Proteomics 11(6), M111.013854 (2012
114. Dupuis A, Hennekinne JA, Garin J, Brun V. Protein standard absolute quantification (PSAQ) for improved investigation of staphylococcal food poisoning outbreaks. Proteomics 8(22), 4633-4636 (2008
115. Jaquinod M, Trauchessec M, Huillet C et al. Mass spectrometry-based absolute protein quantification: PSAQ™ strategy makes use of "noncanonical" proteotypic peptides. Proteomics 12(8), 1217-1221 (2012
116. Huillet C, Adrait A, Lebert D et al. Accurate quantification of cardiovascular biomarkers in serum using Protein Standard Absolute Quantification (PSAQ™) and selected reaction monitoring. Mol. Cell. Proteomics 11(2), M111.008235 (2012
117. Agger SA, Marney LC, Hoofnagle AN. Simultaneous quantification of apolipoprotein a-I and apolipoprotein B by liquid chromatography-multiple reaction monitoring-mass spectrometry. Clin. Chem. 56(12), 1804-1813 (2010
118. Hoofnagle AN, Wener MH. The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry. J. Immunol. Methods 347(1-2), 3-11 (2009
119. Browne TR. Stable isotopes in pharmacology studies: Present and future. J. Clin. Pharmacol. 26(6), 485-489 (1986 (Pubitemid 16095938)
120. Parsons HG. Stable isotopes in the management and diagnosis of inborn errors of metabolism. Can. J. Physiol. Pharmacol. 68(7), 950-954 (1990 (Pubitemid 20242620)
121. Picard G, Lebert D, Louwagie M et al. PSAQ™ standards for accurate MS-based quantification of proteins: From the concept to biomedical applications. J. Mass Spectrom. 47(10), 1353-1363 (2012
122. Picotti P, Bodenmiller B, Mueller LN, Domon B, Aebersold R. Full dynamic range proteome analysis of S. cerevisiae by targeted proteomics. Cell 138(4), 795-806 (2009
123. Fortin T, Salvador A, Charrier JP et al. Multiple reaction monitoring cubed for protein quantification at the low nanogram/milliliter level in nondepleted human serum. Anal. Chem. 81(22), 9343-9352 (2009
124. Hunter C. MRM3 quantitation for highest selectivity of proteins in complex matrices. J. Biomol. Tech. 21(3 Suppl.), S34-S35 (2010
125. Shi T, Su D, Liu T et al. Advancing the sensitivity of selected reaction monitoring-based targeted quantitative proteomics. Proteomics 12(8), 1074-1092 (2012
126. Percy AJ, Chambers AG, Parker CE, Borchers CH. Absolute quantitation of proteins in human blood by multiplexed multiple reaction monitoring mass spectrometry. Methods Mol. Biol. 1000, 167-189 (2013
127. Abbatiello SE, Mani DR, Keshishian H, Carr SA. Automated detection of inaccurate and imprecise transitions in peptide quantification by multiple reaction monitoring mass spectrometry. Clin. Chem. 56(2), 291-305 (2010
128. Kiyonami R, Schoen A, Prakash A et al. Increased selectivity, analytical precision, and throughput in targeted proteomics. Mol. Cell. Proteomics 10(2), M110.002931 (2011
129. Röst H, Malmström L, Aebersold R. A computational tool to detect and avoid redundancy in selected reaction monitoring. Mol. Cell. Proteomics 11(8), 540-549 (2012
130. Gillet LC, Navarro P, Tate S et al. Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: A new concept for consistent and accurate proteome analysis. Mol. Cell. Proteomics 11(6), O111.016717 (2012
131. Hoofnagle AN. Quantitative clinical proteomics by liquid chromatography-Tandem mass spectrometry: Assessing the platform. Clin. Chem. Lab. Med. 56(2), 161-164 (2010
132. Lehmann S, Hoofnagle A, Hochstrasser D et al. Quantitative clinical chemistry proteomics (qCCP) using mass spectrometry: General characteristics and application. Clin. Chem. Lab. Med. 51(5), 919-935 (2013
133. Gallien S, Duriez E, Demeure K, Domon B. Selectivity of LC-MS/MS analysis: Implication for proteomics experiments. J. Proteomics 81, 148-158 (2013
134. Boja ES, Jortani SA, Ritchie J et al. The journey to regulation of protein-based multiplex quantitative assays. Clin. Chem. 57(4), 560-567 (2011
135. Bell AW, Deutsch EW, Au CE et al. A HUPO test sample study reveals common problems in mass spectrometry-based proteomics. Nat. Methods 6(6), 423-430 (2009
136. Hermjakob H. The HUPO proteomics standards initiative-overcoming the fragmentation of proteomics data. Proteomics 6(Suppl. 2), 34-38 (2006 (Pubitemid 44625766)
137. Legrain P, Aebersold R, Archakov A et al. The human proteome project: Current state and future direction. Mol. Cell. Proteomics 10(7), M111.00993 (2011
138. Wright GW, Cazares LH, Leung SM et al. Proteinchip(R) surface enhanced laser desorption/ionization (SELDI) mass spectrometry: A novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures. Prostate Cancer Prostatic Dis. 2(5/6), 264-276 (1999 (Pubitemid 30252204)
139. Petricoin EF, Ardekani AM, Hitt BA et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359(9306), 572-577 (2002 (Pubitemid 34178440)
140. Baggerly KA, Morris JS, Coombes KR. Reproducibility of SELDI-TOF protein patterns in serum: Comparing datasets from different experiments. Bioinformatics 20(5), 777-785 (2003 (Pubitemid 38443834)
141. Prakash A, Rezai T, Krastins B et al. Platform for establishing interlaboratory reproducibility of selected reaction monitoring-based mass spectrometry peptide assays. J. Proteome Res. 9(12), 6678-6688 (2010
142. Percy AJ, Chambers AG, Smith DS, Borchers CH. Standardized protocols for quality control of MRM-based plasma proteomic workflow. J. Proteome Res. 12(1), 222-233 (2013